These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6204139)

  • 21. Vasopressin-induced increase in total peripheral resistance in deoxycorticosterone acetate hypertensive rats is buffered by the baroreceptor reflex.
    Rascher W; Lang RE; Taubitz M; Meffle H; Unger T; Ganten D; Gross F
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():153s-156s. PubMed ID: 7188584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R; St-Louis J; Schiffrin EL
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central vasopressin is required for the complete development of deoxycorticosterone-salt hypertension in rats with hereditary diabetes insipidus.
    Liang J; Toba K; Ouchi Y; Nagano K; Akishita M; Kozaki K; Ishikawa M; Eto M; Orimo H
    J Auton Nerv Syst; 1997 Jan; 62(1-2):33-9. PubMed ID: 9021647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension.
    Fernandes S; Bruneval P; Hagege A; Heudes D; Ghostine S; Bouby N
    Endocrinology; 2002 Jul; 143(7):2759-66. PubMed ID: 12072411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
    Intengan HD; He G; Schiffrin EL
    Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex difference in the development of deoxycorticosterone-salt hypertension in the rat.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    Hypertension; 1987 Feb; 9(2):172-7. PubMed ID: 3818014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
    Stallone JN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body fluid distribution in the maintenance of DOCA-salt hypertension in rats.
    Tajima Y; Ichikawa S; Sakamaki T; Matsuo H; Aizawa F; Kogure M; Yagi S; Murata K
    Am J Physiol; 1983 May; 244(5):H695-700. PubMed ID: 6846557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of eicosanoids on renal function of DOCA-salt hypertensive rats.
    Roman RJ; Kaldunski ML; Mattson DL; Mistry M; Nasjletti A
    Hypertension; 1988 Sep; 12(3):287-94. PubMed ID: 3169943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.
    Trinder D; Phillips PA; Risvanis J; Stephenson JM; Johnston CI
    Hypertension; 1992 Oct; 20(4):569-74. PubMed ID: 1398892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
    O'Donaughy TL; Brooks VL
    Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
    Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.